Clinical Evaluation of irritation potential of Hair Care formulation on healthy human subjects - NI

Dabur International Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1) Asian Indian male and female subjects
•2) Healthy human subjects (no infectious and evolutive pathology which could make the
•subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check-up)
•3) Between 18 and 65 years of age
•4) Skin is healthy on the studied anatomic unit (free of eczema,wounds, inflammatory scar….)
•5)subjects who show no allergic / irritation symptoms to the test product at skin sensitivity test will be enrolled in the study.

•1 For female: Being pregnant or breastfeeding or having stopped to
•breastfeed in the past three months
•2 Having refused to give his/her assent by not signing the consent
•3 Taking part in another study liable to interfere with this study
•4 Being diabetic.
•5 Being asthmatic.
•6 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the
•only medication permitted is paracetamol).
•7 Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin).
•8 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
•9 Having undergone a surgery requiring a general anaesthesia of more than one hour in the past 6 months.

发起方